Pentraxin 3 production in the adipose tissue and the skeletal muscle in diabetic-obese mice

American Journal of the Medical Sciences

Volumn 347, Issue 3, 2014, Pages 228-233

  Miyaki, Asako ^a   Choi, Youngju ^a   Maeda, Seiji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Diabetes mellitus; GLUT4; Inflammation; Obesity

Indexed keywords

CHOLESTEROL; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; PENTRAXIN 3; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC OBESITY; DIET RESTRICTION; EPIDIDYMIS FAT; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SOLEUS MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; C-REACTIVE PROTEIN; DIABETES MELLITUS; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; MALE; MICE; MICE, OBESE; MUSCLE, SKELETAL; OBESITY; SERUM AMYLOID P-COMPONENT;

EID: 84896691687     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31828341af     Document Type: Article

References (28)

1. Guilherme A, Vibasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev 2008;9:367-77.
2. Hotamisligil GS. Mechanisms linking obesity with cardiovascular disease. Nature 2006;444:875-80.
3. Clement K, Langin D. Regulation of inflammation-related genes in human adipose tissue. J Intern Med 2007;262:422-30.
4. Eckardt K, Sell H, Eckel J. Novel aspects of adipocyte-induced skeletal muscle insulin resistance. Arch Physiol Biochem 2008;114:287-98.
5. Armoni M, Harel C, Karnieli E. Transcriptional regulation of the GLUT4 gene: From PPAR-g and FOXO1 to FFA and inflammation. Trend Endocrinol Metab 2007;18:100-7.
6. Gaster M, Staehr P, Beck-Nielsen H, et al. GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes 2001;50:1324-9.
7. Figueras M, Olivan M, Busquets S, et al. Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: Improvement of the inflammatory status. Obesity 2011;19:362-9.
8. Suzuki W, Iizuka S, Tabuchi M, et al. A new mouse model of spontaneous diabetes derived from ddY strain. Exp Anim 1999;48:181-9.
9. Miura T, Suzuki W, Ishihara E, et al. Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: A new genetic animal model of type 2 diabetes. Eur J Endocrinol 2001;145:785-90.
10. Shimada T, Kudo T, Akase T, et al. Preventive effects of Bofutsushosan on obesity and various metabolic disorders. Biol Pharm Bull 2008; 31:1362-7.
11. Presta M, Camozzi M, Salvatori G, et al. Role of soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007; 11:723-38.
12. Norata GD, Marchesi P, Krishna V, et al. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 2009;120:699-708.
13. Salio M, Chimenti S, Angelis ND, et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2008;117:1055-64.
14. Dias AM, Goodman AR, Dos Santos JL, et al. TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J Leukoc Biol 2001;69:928-36.
15. Osorio-Conles O, Guitart M, Chacon MR, et al. Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, while visceral adipose tissue PTX3 gene expression is increased in obesity. Am J Physiol 2011;301:E1254-61.
16. Chu SH, Park JH, Lee MK, et al. The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention. Clin Chim Acta 2012;413:1430-7.
17. Iemitsu M, Miyauchi T, Maeda S, et al. Intense exercise causes decrease in expression of both endothelial NO synthase and tissue NOx level in hearts. Am J Physiol 2000;279:R951-9.
18. Dietze D, Koenen M, Röhrig K, et al. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 2002;51:2369-76.
19. Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 2008;94:206-18.
20. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: Modulation by nutrients and inflammation. J Clin Invest 2008;118:2992-3002.
21. Sell H, Eckel J, Dietze-Schroeder D. Pathways leading to muscle insulin resistance-The muscle-fat connection. Arch Physiol Biochem 2006;112:105-13.
22. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 2000;1:47-56.
23. Charron MJ, Katz EB, Olson AL. GLUT4 gene regulation and manipulation. J Biol Chem 1999;274:3253-6.
24. Introna M, Alles VV, Castellano M, et al. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 1996;87:1862-72.
25. Mallat Z, Tedgui A. HDL, PTX3, and vascular protection. Arterioscler Thromb Vasc Biol 2008;28:809-11.
26. Sowers Jr. Insulin resistance and hypertension. Am J Physiol 2004; 286:H1597-602.
27. Abderrahim-Ferkoune A, Bezy O, Chiellini C, et al. Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. J Lipid Res 2003;44:994-1000.
28. Alberti L, Gilardini L, Zulian A, et al. Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Atherosclerosis 2009;202:455-60.